News
GlaxoSmithKline LLC (GSK) plans to lay off 150 Cambridge workers. The layoffs come months after GSK said it had planned to ...
GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity ...
Martha Sazon, president and chief executive of Mynt, the company behind mobile wallet GCash, has been instrumental in ...
This month in the Zantac litigation, the Delaware Supreme Court tossed all the plaintiffs’ experts in thousands of cases, ...
AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...
The analyst further reasoned that the high ocular toxicity rates, including keratopathy and visual acuity changes, are ...
Explore more
U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's decision to discontinue a widely used asthma inhaler for children.
The FDA's ODAC voted that the benefit-risk profile of belantamab mafodotin in multiple myeloma were not favorable, ...
Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Vishwanath Swarup as Commercial Head - ...
Proposals by Robert F. Kennedy Jr. and Bernie Sanders range from more disclosures in commercials to an outright ban.
11d
BUCKSCO.Today on MSNGlaxosmithkline Gets Approval for First-of-its-Kind Lupus TreatmentGlaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus ...
12d
MedPage Today on MSNMetformin Offers No Survival Boost in Metastatic Prostate CancerSTAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer progression or survival benefits to metformin across disease stages. Gillessen's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results